Search by Drug Name or NDC

    NDC 41163-0381-01 Equaline Mucus Relief 325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1 Details

    Equaline Mucus Relief 325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1

    Equaline Mucus Relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Supervalu Inc. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 41163-0381
    Product ID 41163-381_39e27ab6-7c07-489e-88cf-8c7fd6e73a31
    Associated GPIs 43998304100320
    GCN Sequence Number 060553
    GCN Sequence Number Description phenylephrine/DM/acetaminop/GG TABLET 5-325-200 ORAL
    HIC3 B4P
    HIC3 Description NON-OPIOID ANTITUSS-DECONGESTANT-ANALGESIC-EXPECT
    GCN 26742
    HICL Sequence Number 035445
    HICL Sequence Number Description PHENYLEPHRINE HCL/DEXTROMETHORPHAN HBR/ACETAMINOPHEN/GUAIFEN
    Brand/Generic Generic
    Proprietary Name Equaline Mucus Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 325; 10; 200; 5
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Supervalu Inc
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2023-12-31

    Package

    NDC 41163-0381-01 (41163038101)

    NDC Package Code 41163-381-01
    Billing NDC 41163038101
    Package 10 BLISTER PACK in 1 CARTON (41163-381-01) / 2 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2013-12-12
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 67193139-768d-4c96-9056-545a6db7bd31 Details

    Revised: 12/2019